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Abstract
Background: Hospital readmissions remain highly prevalent despite being the target of policies and financial
penalties. Evidence comparing the effectiveness and costs of interventions to reduce readmissions is lacking,
leaving healthcare systems with little guidance on how to improve quality and avoid costly penalties. Effective
interventions likely need to bridge inpatient and outpatient settings, incorporate information technology, and use
dedicated providers. Such complex innovations will require rigorous evaluation. The framework of quality
improvement research provides an approach that both improves care locally and contributes to closing the
current knowledge gaps for readmissions. In this trial, we will study a comprehensive intervention that incorporates
these recommendations into an integrated practice unit, called transition services, with an aim of reducing 30-day
readmission rates.
Methods/design: We describe a nonblinded, pragmatic, controlled trial with two parallel groups comprising
an evaluation of the effect of referral to a provider-led integrated practice unit, inclusive of comprehensive
multidisciplinary care, dedicated paramedicine providers, and virtual visits, on 30-day readmission rates for
high-risk hospitalized patients. An automated risk-scoring system will randomly generate referrals to either
transition services or usual care for 1520 hospitalized patients who score as high-risk for readmission. Transition services
will then engage with patients in the hospital setting using a patient navigator and provide bridging outpatient
services for the 30 days following discharge. All outcome data are retrieved electronically from administrative
medical records. After reapplication of inclusion and exclusion criteria at the time of hospital discharge, analyses
will follow the intention-to-treat principle such that patients will be analyzed on the basis of the referral group to
which they were initially randomized.
Discussion: The hospital transition program under study is complex and integrates the latest recommendations
for readmission reduction strategies. As healthcare systems innovate to address readmissions through such complex
interventions, there is significant benefit for stakeholders to have a clear understanding of the potential reach, cost, and
real-world effectiveness. The pragmatic methods described here provide a template for conducting quality improvement
research that fits seamlessly into existing care delivery and improvement efforts, leading to better-informed strategic
decisions and the investments necessary to transform care and value for patients.
Trial registration: ClinicalTrials.gov, NCT02763202. Registered 3 March 2016 (retrospectively registered).
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Background
Hospital readmissions are highly prevalent, costly, and
associated with poor outcomes [1]. As a result, readmis-
sion reduction strategies have been an early target of
policy changes and related financial penalties designed
to drive quality improvement [1–5]. Beginning in 2012,
the Affordable Care Act established a Hospital Readmis-
sions Reduction Program (HRRP) authorizing Medicare
to decrease payments to hospitals with excess readmis-
sion rates (https://www.medicare.gov/hospitalcompare/
readmission-reduction-program.html). A recent analysis
showed that, compared with the year 2007 readmission
rates, the 2015 readmission rates indeed declined by an
average of 2% for Medicare beneficiaries but still remain
at approximately 18% for patients with conditions
targeted by HRRP (myocardial infarction, pneumonia,
and heart failure) [2].
For hospitals seeking guidance on improving readmis-
sions and avoiding financial penalties, high-quality evi-
dence comparing the effectiveness of interventions and
related costs is limited and conflicting [3]. Authors of
reviews have found no consistent evidence that single in-
terventions produce significant reductions in readmission
rates; however, the evidence appears promising for multi-
faceted interventions bridging the pre- and postdischarge
periods [6, 7]. Despite these findings, the most recent
large, randomized trial of a postdischarge virtual ward in
Canada showed no statistically significant effect on re-
admission and death [8]. Given the uncertainty of effect-
iveness and the considerable associated costs, the next
generation of multifaceted interventions should be evalu-
ated through rigorous, pragmatic evaluations that clearly
identify target populations, cost, and specific implementa-
tion factors to optimize generalizability and inform future
directions [3, 9–11].
Current evidence suggests this next generation of hos-
pital transition interventions should use analytics to
focus on the patients at highest risk for a readmission
while incorporating the following: (a) integration of in-
formation technology, (b) home-based interventions, (c)
new types of transitional care personnel, (d) dedicated
transition personnel, and (e) interventions spanning both
inpatient and outpatient delivery settings [10]. Our local
healthcare system adopted these recommendations into
its efforts to improve readmissions by developing a
comprehensive program called transition services. This
program is based on the integrated practice unit (IPU)
model that includes physician-led, team-based, inte-
grated services focused on a specific segment of the
population [12].
To properly evaluate this transition services program, we
designed a randomized quality improvement trial, titled
“Aiming to Improve Readmissions Through InteGrated
Hospital Transitions” (AIRTIGHT), in which pragmatic
methods are used to match the trial design to how the re-
sults will be used [13]. This quality improvement research
approach is explicitly designed to both improve care locally
and contribute to general scientific knowledge [14]. By
incorporating the rigor of research methodologies such as
randomization, quality improvement research seeks to gen-
erate valid and generalizable information that will guide
the continuous process of improving care delivery [11, 15].
Similarly, pragmatic trials are designed to determine the
effects of an intervention in the “real-world” setting, thus
generating results with broad applicability [13, 16]. The
Pragmatic-Explanatory Continuum Indicator Summary 2
(PRECIS-2) tool provides a framework for guiding prag-
matic trial design to optimize applicability and can be
applied to the design of quality improvement research
studies [13]. PRECIS-2 assumes that trials have two study
arms with unchanged usual care serving as the comparator
and contains nine domains representing the applicability of
the trial’s eventual results to real healthcare settings. This
paper outlines the AIRTIGHT study protocol following
both the Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) guidelines for intervention
trials and the PRECIS-2 criteria for pragmatic trials
[13, 17]. (The SPIRIT checklist and figure are included as
Additional files 1 and 2.)
Methods/design
Overview
AIRTIGHT is a nonblinded, pragmatic, controlled trial
with two parallel groups in which we are evaluating the
effect of referral to a provider-led IPU, inclusive of com-
prehensive multidisciplinary care and virtual visits, on
30-day readmission rates for high-risk hospitalized pa-
tients (Fig. 1). The primary outcome of 30-day, all-cause,
any-site readmission will be retrieved electronically from
administrative medical record data. Secondary outcomes
will all be retrieved in a similar fashion and include 30-
day single-site readmission, emergency department use,
60- and 90-day readmissions, length of stay on index ad-
mission and readmission, and cost. To provide an under-
standing of implementation factors, the RE-AIM (Reach,
Effectiveness, Adoption, Implementation, Maintenance)
framework is incorporated into the study design [18].
The trial is pragmatic across all nine PRECIS-2 domains
(Fig. 2). In keeping with this pragmatic framework, the
research team has no contact with participants during
any aspect of the evaluation. Randomization, patient
tracking, and outcomes are all conducted electronically.
The AIRTIGHT trial is registered with ClinicalTrials.gov
(NCT02763202).
Study setting
The transition services program will be evaluated in pa-
tients under the care of a hospitalist at a tertiary hospital
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and a smaller satellite hospital, both located within a large
integrated healthcare system in Charlotte, NC, USA.
Eligibility
Patients are eligible for referral if they are over the age
of 18 years, are seen by a hospitalist, and have been cate-
gorized as an inpatient and as high-risk for readmission,
defined as a risk score probability during the first 72 h
of admission that is associated with a readmission rate
greater than 20%. Patients are excluded if they have a
primary residence more than 150 miles from the hos-
pital; are admitted from or discharged to locations such
as hospice, skilled nursing facility (SNF), or jail; leave the
hospital against medical advice; have an acute psychiatric
illness; have been referred as part of the AIRTIGHT
evaluation in the previous 90 days; have attended a simi-
lar heart failure transitions clinic at discharge; or are
being actively care managed for a cancer diagnosis or
sickle cell disease. These latter groups have existing,
robust care management services in place. Transition
services was specifically designed to support the unique
needs of patients being discharged to home; conse-
quently, SNF patients were excluded, despite this being a
group at high risk for readmission. Also, because the
intervention is designed to begin during a patient’s
hospital stay, the initial referrals occur early in the
course of the hospitalization. However, because we ex-
pect changes in some patients’ criteria during the ensu-
ing hospitalization course, the inclusion and exclusion
criteria are applied again at discharge (Fig. 1, “Eligible at
discharge” bubble).
Risk score
The readmission risk model used is a neural network. It
is built from a final set of 71 variables after the assess-
ment of several thousand variables consisting of demo-
graphic, clinical, and use data. The model was built
using retrospective information but is applied in a nearly
real-time setting during a patient’s inpatient admission.
Model performance was determined using a training
dataset (70%) as well as a testing dataset (30%), as is
typical in predictive model development. Operation-
ally, scoring data for the model are sourced from a
patient’s billing history (at the time of admission) as
well as using clinical data updated throughout the
hospital stay. Examples of information leveraged in
the model include variables such as albumin, ammonia,
body mass index, fall risk score, inability to verbalize
needs, insurance type, living situation, oxygen flow rate,
and pain intensity.
Fig. 1 Study design and patient flow
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Every 1–4 h, a patient’s readmission risk is assessed via
the model, and a risk score between 0 and 1 is calculated.
This value is then attributed to one of four segments that
convey increasing risk of readmission (low, moderate,
high, or very high). Outside this study, clinicians use this
risk information to assist in discharge planning.
Randomization and blinding
A referral list is generated each weekday morning by
randomly selecting eligible patients during their initial
72 h of admission. A six-person block randomization
scheme was used so that, at any point, there are three
patients assigned to usual care and three patients
assigned to the transition services program. SAS soft-
ware (SAS Institute, Cary, NC, USA) was used to create
this 1:1 allocation, with future allocations concealed
from the clinical team [19]. The total referrals are
constrained to no more than 30 patients per day, but
the total may be adjusted downward on the basis of
daily estimates of the transition services’ capacity.
Given the nature of the intervention, it is not possible
to blind patients or clinicians. For the interim and
final outcome analyses, a study statistician and Data
and Safety Monitoring Board (DSMB) are not blinded
to treatment assignment.
Trial intervention and control
Control patients will receive usual care. Standard dis-
charge care at both hospitals includes recommendations
for follow-up appointments with a patient’s primary care
physician, discharge summaries sent to primary care phy-
sicians, the arrangement of home health services based on
each patient’s needs, and other outreach interventions
such as follow-up care management phone calls.
In addition to usual care, patients referred to the inter-
vention group are contacted during their hospital stay by
a registered nurse patient navigator, invited to participate
in the transition services program, and then followed for
the remainder of their hospital stay. For 30 days follow-
ing discharge, patients have access to the transition
services program, which, in addition to a free-standing
clinic, includes the following: (a) as-needed access to
transition-dedicated internal medicine, pharmacist, para-
medicine, behavioral health, and care management pro-
viders; (b) hospital follow-up evaluation with a medical
provider, either virtually in the patient’s home facilitated
by a paramedicine provider or in the transition clinic; (c)
medication reconciliation by a pharmacist; (d) at least
weekly contact with the care management team; (e) 24/7
phone support, 24/7 paramedicine visit availability, and
same-day clinic scheduling; and (f) coordinated transition
Fig. 2 Pragmatic-Explanatory Continuum Indicator Summary 2 (PRECIS-2) tool. This framework contains nine domains representing the applicability of
the trial’s eventual results to real-world healthcare settings
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to the next appropriate care location after 30 days
(Table 1). The intensity of the care provided is not pre-
scribed but rather dictated by the care team and patient.
At a minimum to qualify as having participated, patients
will have an in-person or virtual visit with the transition
services medical provider. Patients or their insurance pro-
viders are charged only for services that are billable under
usual care, whereas all other services are provided by the
healthcare system as part of care management.
Outcomes
The primary outcome is the rate of 30-day, nonelective
readmissions to any of the 30 hospitals affiliated with
the sponsoring healthcare system. We followed the def-
inition for nonelective readmissions as set out by the
Centers for Medicare and Medicaid Services (CMS);
however, we included both inpatient and observation
classifications to create an outcome that is more patient-
centered (Fig. 3). To allow for nondifferential outcome
assessment, we use only data that are collected and
available as part of routine care. Secondary outcomes in-
clude the 30-day nonelective readmission rates separated
by inpatient and observation classifications (Fig. 3), 30-
day emergency department use, 30-day acute care use
composite (primary outcome of readmission plus emer-
gency department use), 60- and 90-day readmission rates
(using primary outcome definition of readmission), and
length of stay on index and readmission visit. Addition-
ally, in cost analysis, we will compare the total patient
charges at 30, 60, and 90 days across groups with model-
ing of cost inclusive of estimated readmission penalties.
To provide an understanding of implementation factors,
RE-AIM measures are reported to the care team through
monthly automated reports (Table 2) [18]. Because
this evaluation is also designed to inform a quality
improvement project, we expect that the clinical team
may use the RE-AIM measures to adapt the transition
services program during the course of the evaluation.
Any substantial changes in process, procedures, or
services will be documented and incorporated into
the outcome analyses.
Sample size
This study is designed to detect a 30% relative reduction
in the readmission rate, with the usual care group
assumed to have a 20% readmission rate in 30 days. A
relative reduction of 30% was based on estimates from
randomized controlled trials looking at bundled transition
Table 1 Transition services program intervention components
Transition services components Transition recommendations [10] and drivers of readmissions
addressed
Referral to transition services program and introduction by patient navigator
while patient is still hospitalized
• Dedicated transition personnel
• Spanning inpatient and outpatient
• Engagement
• Discharge plan confusion
Comprehensive postdischarge evaluation by internal medicine physician • Dedicated transition personnel
• Spanning inpatient and outpatient
• Access
• Timely follow-up of items outstanding at discharge
• Early identification of change in patient status
Postdischarge medication reconciliation by a pharmacist • Dedicated transition personnel
• Medication errors, misunderstanding, adherence
In-home virtual appointments • Home-based interventions
• Integration of IT
• Access
24/7 availability of dedicated paramedicine team for in-home visits • Home-based interventions
• New types of transitional care personnel
• Dedicated transition personnel
• Access
• Coordinated service between home and clinic
Multidisciplinary team (internal medicine, pharmacist, paramedicine, behavioral
health, and care management providers)
• Dedicated transition personnel
• Access to comprehensive follow-up services
Regular care management contact starting with discharge follow-up call and
weekly thereafter
• Dedicated transition personnel
• Coordinated care
• Engagement
Real-time population health dashboards for clinic staff • Integration of IT
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interventions and intensive home interventions [9, 20–22].
We will have 80% power to detect this reduction (transi-
tion services group rate reduced to 14%) with a total sam-
ple size of 1230 (α = 0.05) using a chi-square test for
independence. Assuming 10% of those assigned to transi-
tion services will not participate, we must increase our
sample size to 1520 (n = 760 per arm) to account for the
anticipated decrease in the effect size. At the time of proto-
col design, available historical data included only the more
narrow CMS definition of single-site readmissions (second-
ary outcome). Thus, the assumptions used in the power
analysis are reflective of more conservative estimates
than would be expected for the primary outcome
measure’s expanded definition for readmission, which
includes inpatient and observation stays between any
of the acute care hospitals.
Data collection
Each weekday morning, a list of eligible patients in both
arms of the study is generated and stored in an SAS
dataset. Patients randomized to referral to the transition
services program have their information exported to an
Fig. 3 Patient-centered readmission. *The primary outcome is the difference in 30-day readmission rates between facilities. A readmission visit
can be either an inpatient or an observation visit. Secondary outcomes include the difference in 30-day readmission rates between facilities. In
one analysis, a readmission visit can only be an inpatient visit, and in another analysis a readmission visit can only be an observation visit
Table 2 RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework
RE-AIM measure Metrics
Reach: How do I reach the target population? • Capture rate: proportion of patients interested in program participation out
of those who are referred and appropriate at the time of discharge
• Show rate: proportion of patients who have a visit with the program out
of those who are referred and appropriate at the time of discharge
Effectiveness: How do I know my intervention is effective? • Absolute and observed/expected 30-day readmission rates as defined by
CMS and reported as a routine quality metric by the healthcare system
Adoption: How do I develop organization support to
deliver my intervention?
• Qualitative evaluation of program and participating primary care providers,
which will be reported separately
Implementation: How do I ensure the intervention is
delivered properly?
• Absolute and mean visit counts and visit type by month for the clinic
as a whole and per patient
• Proportion of patients with a medicine reconciliation and provider visit
in 72 h out of all participating patients
Maintenance: How do I incorporate the intervention
so it is delivered over the long term?
• Institutional level: Reach, Effectiveness, and Implementation measures
for 3 months after conclusion of trial
• Patient level: 90-day readmission and composite ED and hospitalization rates
• Patient level: Qualitative substudy evaluating effect of intervention more
than 60 days after last contact
CMS Centers for Medicare and Medicaid Services, ED Emergency department
McWilliams et al. Trials  (2016) 17:603 Page 6 of 9
Excel file (Microsoft, Redmond, WA, USA) for use by
the nurse patient navigator. It is within this file that the
enrollment status is tracked by the nurse patient naviga-
tor. A patient’s choice to decline services through the
transition services program is also tracked within this
file. The day following list generation, enrollment status
is incorporated into the SAS dataset.
Patient data such as demographics and information
associated with their hospital encounters, emergency
department encounters, and charges will be pulled from
tables within the healthcare system’s enterprise data
warehouse. Dashboards displaying patient demographics,
appointment descriptions (i.e., arrived, no show, can-
celed visit), enrollment rates, and no-show rates are
presented to the clinical teams in Tableau files [23].
Analysis
All analyses will follow intention-to-treat principle such
that patients will be analyzed on the basis of the group
to which they were initially randomized, but after re-
application of inclusion and exclusion criteria at the time
of hospital discharge (Fig. 1, “Eligible at discharge” bub-
ble). Baseline comparisons of the two groups will be
made using univariate analyses such as the t test and
chi-square test. The primary outcome, readmission in
30 days, will be compared between the two groups of
patients who are eligible at discharge, using logistic re-
gression. Results will be presented with ORs and 95%
CIs. In addition to the intention-to-treat analysis, we will
perform a per-protocol analysis to evaluate the patients
who are eligible at discharge and participate in the tran-
sition services program compared with usual care pa-
tients who are eligible at discharge. For all outcomes, we
assume that if there are no visits in the electronic med-
ical record, the value for having a visit is null; therefore,
there will be no missing data for the primary or second-
ary outcome measures.
Interim analysis and Data and Safety Monitoring Board
An unblinded statistician will conduct an interim effi-
cacy analysis on the primary outcome of 30-day re-
admission rates once 50% of patients have been accrued
in the trial and have 30-day outcomes. We will use the
Haybittle-Peto procedure with a large critical value (z
score ±3.0, two-sided α = 0.0027) [24]. Given the single
planned interim analysis, no adjustment to the final crit-
ical value is needed [24]. At the same time, we will also
conduct a futility analysis in which we will estimate the
conditional power under the null hypothesis of no differ-
ence and the designed alternative of 30% reduction in
the 30-day readmission rate. Conditional power is the
probability of detecting a difference at the end of the
study (p < 0.05), given the data trends at the time of the
analysis. A recommendation will be made to stop the
study for futility if the conditional power is less than
0.10. In addition to the interim efficacy and futility ana-
lyses, a sample size reestimation will also be conducted
that is based on the overall readmission rate and the rate
of dropouts from the intervention group, The DSMB will
be composed of a senior biostatistician and three clini-
cians who are not affiliated with the research team. The
DSMB will make recommendations to the study’s princi-
pal investigator and an executive steering committee with
oversight of the evaluation.
Ethics
The trial was approved by the Carolinas HealthCare
System Institutional Review Board and granted a waiver
for patient consent (reference number 01-15-10E).
Discussion
The AIRTIGHT trial will provide important information
to healthcare systems that currently have little evidence-
based guidance for efforts to improve readmission rates
and avoid financial penalties. First, though some trials have
suggested that multifaceted interventions have potential
benefit, others have suggested no benefit [6–8, 20, 22].
AIRTIGHT is the first U.S. randomized study within a
large, integrated healthcare delivery system to examine the
effectiveness of an intensive intervention that bridges the
pre- and postdischarge periods while incorporating the
most recent recommendations for hospital transitions, vir-
tual care, and dedicated paramedicine providers. Second,
the pragmatic design of this study will create information
that is generalizable to other healthcare systems. We have
intentionally applied the PRECIS-2 tool to match the study
design to how the evidence is intended to be implemented
[13]. Although randomizing patient referrals with limited
inclusion and exclusion criteria increases the risk of effect-
size attenuation and the study being underpowered, there
is significant benefit for stakeholders to have a clear under-
standing of the potential reach and real-world effectiveness
of the intervention. Third, the methods of the AIRTIGHT
trial provide a template for healthcare systems to conduct
quality improvement research that fits seamlessly into
existing care delivery and quality improvement efforts. To
ensure both the relevance of the questions asked and the
seamless integration of the trial into clinical workflows, we
formed an executive steering committee. The executive
steering committee includes representation from health-
care system senior leadership and each of the major disci-
plines involved in the transition services program.
As the paradigm of healthcare delivery continues to
evolve rapidly, the imperative increases for healthcare
systems to have real-time, reliable information upon
which to act. These methods should be leveraged to
guide continuous improvement, strategic decisions, and
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investments that are necessary to transform care and
value for patients.
This study has several potential limitations. First, al-
though there are few exclusion criteria, generalizability
could be threatened by the study being contained within
one healthcare system. Despite this, patients are ex-
pected to be broadly representative of the general popu-
lation that is at high risk for readmission because of the
racially, ethnically, and geographically diverse population
served by this healthcare system. Second, because we do
not have access to payer-level claims data, outcomes
analysis is limited to the 30 hospitals contributing clinical
data to the study. If a difference in rates of hospitalization
outside these 30 hospitals exists between groups, it would
be expected to bias the results toward the null. Such a dif-
ference is expected because the intervention group partici-
pants should be more likely to return to the sponsoring
health system’s hospitals owing to the ongoing contact
with transition services personnel. Third, given the com-
plex nature of the transition services intervention, we will
not be able to isolate the effects of individual intervention
components. Transition services is designed to encompass
the current literature recommendations for a multifaceted
intervention with the expectation that health systems
would look to replicate the intervention and not its
subcomponents. However, to provide an additional
layer of understanding of both the intervention’s com-
ponents and its implementation, a separate qualitative
study will be conducted.
Trial status
This trial is currently enrolling participants. Data collection
began on 8 February 2016.
Additional files
Additional file 1: SPIRIT 2013 checklist: recommended items to address
in a clinical trial. (PDF 106 kb)
Additional file 2: Schedule of enrollment, interventions, and assessments.
(PDF 75 kb)
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